|
| |
|
Sify.com » Topics » Ranjit Kapadia
Ranjit Kapadia News
FIIs, MFs reduce Piramal holding Stock down 37% since Abbott deal Sixteen months after billionaire Ajay Piramal sold the domestic formulations business of his flagship Piramal Healthcare to US-based Abbott Labs for $3.7 billion (Rs 17,000 crore), the Mumbai-based drug maker’s stock seems to have gone out of institutional investors’ radar. The open-ended equity schemes of India’s top fund houses such as Reliance MF,
Mylan challenges nod to Ranbaxy's $600-mn drug
Stock falls 7% after US company sues FDA for giving six-month exclusive rights to market Pfizers Lipitor
Marico whets its appetite for foods
The company’s Rs 200-crore bid for Unibic highlights its seriousness about a segment in which it had been taking small steps.
Disappointing quarter for Ranbaxy Labs
Ranbaxy Laboratories, India’s largest drug company by sales, has registered a net loss of Rs 97.4 crore for the fourth quarter ended December 31, 2010. Revenue for the period was Rs 2,066 crore,
The pharma story: A decade of transition
The last 10 years were a crucial transition period for the Indian pharmaceutical industry. The next 10 years will be more crucial, predict industry experts. |
|
|
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre. Site optimized for Internet Explorer 5.5 and above. See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise | |
